These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1108 related items for PubMed ID: 23485092

  • 1. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [Abstract] [Full Text] [Related]

  • 2. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K, Gelbaya TA, Laing I, Nardo LG.
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [Abstract] [Full Text] [Related]

  • 3. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
    Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E.
    Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
    [Abstract] [Full Text] [Related]

  • 4. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.
    Gleicher N, Weghofer A, Barad DH.
    Fertil Steril; 2010 Dec; 94(7):2824-7. PubMed ID: 20538269
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, Lyu SW, Kim YS, Lee WS, Yoon TK.
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [Abstract] [Full Text] [Related]

  • 6. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 7. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 8. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
    He Y, Xia R, Chen X, Ye D, Tang Y, Li P, Niu J, Chen S.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
    [Abstract] [Full Text] [Related]

  • 9. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [Abstract] [Full Text] [Related]

  • 10. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H.
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [Abstract] [Full Text] [Related]

  • 11. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X, Wang Y, Yang H, Gao T, Yu C, Cao F, Xia X, Wu J, Zhou X, Chen L.
    Sci Rep; 2020 Nov 12; 10(1):19750. PubMed ID: 33184364
    [Abstract] [Full Text] [Related]

  • 12. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, Kuchenbecker WKH, Fleischer K, de Bruin JP, Groen H, van Wely M, Lambalk CB, Laven JSE, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group.
    Hum Reprod; 2017 Dec 01; 32(12):2485-2495. PubMed ID: 29121350
    [Abstract] [Full Text] [Related]

  • 13. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P, Dulęba AJ, Kario A, Chełstowski K, Branecka-Woźniak D, Kurzawa R.
    Hum Reprod; 2019 Nov 01; 34(11):2244-2253. PubMed ID: 31725884
    [Abstract] [Full Text] [Related]

  • 14. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun 01; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 15. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J.
    Gynecol Obstet Fertil; 2012 Jun 01; 40(7-8):411-8. PubMed ID: 22521986
    [Abstract] [Full Text] [Related]

  • 16. Comparing four ovarian reserve markers--associations with ovarian response and live births after assisted reproduction.
    Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J.
    Acta Obstet Gynecol Scand; 2015 Oct 01; 94(10):1056-63. PubMed ID: 26184379
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC, Lee RK, Lin SY, Lin MH, Hwu YM.
    Taiwan J Obstet Gynecol; 2016 Apr 01; 55(2):239-43. PubMed ID: 27125408
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B.
    Arch Gynecol Obstet; 2014 Dec 01; 290(6):1249-53. PubMed ID: 25001569
    [Abstract] [Full Text] [Related]

  • 19. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
    Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH.
    Gynecol Endocrinol; 2014 Jul 01; 30(7):490-3. PubMed ID: 24641676
    [Abstract] [Full Text] [Related]

  • 20. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK, Zosmer A, Tozer A, Sabatini L, Davis C, Al-Shawaf T.
    Reprod Biomed Online; 2012 May 01; 24(5):503-10. PubMed ID: 22417663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.